NCT05639803View on ClinicalTrials.gov

A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

October 22, 2020

Study Completion Date

October 22, 2020

Conditions
Herpes Zoster
Interventions
DRUG

PEGIFNα1b

100μg/vial

DRUG

Placebo

0.5ml/vial

Trial Locations (1)

Unknown

The first affiliated hospital of bengbu medical college, Bengbu

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY

NCT05639803 - A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults | Biotech Hunter | Biotech Hunter